Diagnosis of Alzheimer's disease in Brazil: Diagnostic criteria and auxiliary tests. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology;Diagnóstico de doença de Alzheimer no Brasil: Critérios diagnósticos e exames complementares. Recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 3 A, 2005, Pages 713-719

  Nitrini, Ricardo ^b   Caramelli, Paulo ^b   De Campos Bottino, Cássio Machado ^b   Pereira Damascene, Benito ^b   Dozzi Brucki, Sonia Maria ^b   Anghinah, Renato ^a  

^a Academia Brasileira de Neurologia   (Brazil)

^b NONE

Author keywords

Alzheimer's disease; Brazil; Consensus; Dementia; Diagnosis; Guidelines; Norms

Indexed keywords

AGING; ALZHEIMER DISEASE; BRAZIL; CEREBROSPINAL FLUID EXAMINATION; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROENCEPHALOGRAM; EVIDENCE BASED MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; REVIEW; SEROLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 24144488647     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2005000400033     Document Type: Review

References (69)

1. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1143-1153.
2. Patterson C, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders. Conclusions from the Canadian consensus conference on dementia. Can J Neurol Sci 1999; 160 (Suppl 12):S1-S15.
3. Waldemar G, Dubois B, Emre M, Schelten P, Tariska P, Rossor M. Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. Eur J Neurol 2000;7:133-144.
4. The dementia study group of the Italian neurological society, coordinated by Sandro Sorbi. Guidelines for the diagnosis of dementia and Alzheimer's disease. Neurol Sci 2000;21:187-194.
5. AGS Clinical Committee. Guidelines abstracted from the American Academy of Neurology's dementia guidelines for early detection, diagnosis, and management of dementia. J Am Geriatr Soc 2003;51:869-873.
6. Screening for dementia: recommendation and rationale. US Preventive Services Task Force. Ann Intern Med 2003;138:925-937.
7. Albiusi G, Allegri R, Andrés H, et al. Normativas para el diagnóstico de demencia em general y demencias corticales tipo Alzheimer. Consortium Argentino para el estúdio de la demencia (CAED). Geriatria Práctica 1998;8:4-7.
8. Barbosa JC. Diagnóstico das demências. 2° Congresso Paulista de Geriatria e Gerontologia. GERRP 2001. (versão em CD).
9. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-944.
10. rd Ed. Washington, D.C.: American Psychiatric Association, 1987.
11. th Ed. Washington, D.C.: American Psychiatric Association, 1994.
12. World Health Organization (WHO). The ICD-10 classification of mental and behavioral disorders. Diagnostic criteria for research. Geneva: World Health Organization, 1993.
13. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX - A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
14. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337:1667-1674.
15. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale. J Psychiatr Res 1983;17:37-49.
16. Center for Epidemiological Studies - Depression Scale (CES-D). In Burns A, Lawlor Brian, Craig S (eds) Assessment scales in old age psychiatry. London Martin Dunitz, 1999:14.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
18. Kawas CH. Early Alzheimer's disease. N Engl J Med 2003;349:1056-1063.
19. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
20. Stoppe A Jr, Jacob W Filho, Louzã MR Neto. Avaliação de depressão em idosos através da "Escala de Depressão em Geriatria": resultados preliminares. Rev ABP-APAL 1994;16:149-153.
21. Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999;14:858-865.
22. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for depression in dementia. Biol Psychiatry 1988;23:271-284.
23. Fabbri RM, Moreira MA, Garrido R, Almeida OP. Validity and reliability of the Portuguese version of the Confusion Assessment Method (CAM) for the detection of delirium in the elderly. Arq Neuropsiquiatr 2001;59:175-179.
24. American Psychiatric Association. Practice guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. APA: Washington, DC, 1997;8-10.
25. Nitrini R, Mathias SC, Caramelli P, et al. Evaluation of 100 patients with dementia in São Paulo, Brazil: correlation with socioeconomic status and education. Alzheimer Dis Assoc Disord 1995;9:146-151.
26. Silva DW, Damasceno BP. Demência na população de pacientes do Hospital das Clínicas da UNICAMP. Arq Neuropsiquiatr 2002;60:996-999.
27. Takada LT, Caramelli P, Radanovic M, et al. Prevalence of potentially reversible dementias in a dementia outpatient clinic of a tertiary university-affiliated hospital in Brazil. Arq Neuropsiquiatr 2003;61:881-890.
28. Vale FA, Miranda SJ. Clinical and demographic features of patients with dementia attended in a tertiary outpatient clinic. Arq Neuropsiquiatr 2002;60:548-552.
29. Corey-Bloom J, Thal LJ, Galasko D, et al. Diagnosis and evaluation of dementia. Neurology 1995;45:211-218.
30. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
31. Damasio H, Kuljis RO, Yuh W, Van Hoesen GW, Erhardt J. Magnetic resonance imaging of human intracortical strutcture in vivo. Cerebral Cortex 1991;1:374-379.
32. Gomez-Isla T, Price JL, McKeel DW, et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-4500.
33. Bottino CM, Castro CC, Gomes RL, Buchpiguel CA, Marchetti RL, Neto MR. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 2002;14:59-72.
34. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
35. Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJ, Soininen H. Major decrease in the volume of the entorrhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E E-4 allele. J Neurol Neurosurg Psychiatry 1998;65:322-327.
36. Wahlund LO, Julin P, Lannfelt L, et al. Inheritance of the ApoE epsilon-4 allele increases the rate of brain atrophy in dementia patients. Dement Geriatr Cogn Disord 1999;10:262-268.
37. Small SA, Perera GM, DelaPaz R, et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 1999;45:466-472.
38. Doraiswamy PM, Charles HC, Krishnan KRR. Prediction of cognitive decline in early Alzheimer's disease. Lancet 1998;352:1678.
39. Engelhardt E, Moreira DM, Laks J. Doença de Alzheimer e espectroscopia por ressonância magnética do hipocampo. Arq Neuropsiquiatr 2001;59:865-870.
40. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001;56:592-598.
41. Shonk T, Moats R, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72.
42. Rose S, de Zubicaray G, Wang D, et al. A 1H-MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 1999;17:291-299.
43. Jessen F, Block W, Träber F, et al. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000;55:684-688.
44. Fox NC, Warrington EK, Rossor MN. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 1999;353:2125.
45. Fox NC. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000;57:339-344.
46. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992;33:181-185.
47. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-1571.
48. Jagust W, Thisted R, Devous MD, et al. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology 2001;56:950-956.
49. Kantarci K, Jack CR Jr. Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am 2003;13:197-209.
50. Luccas FJC, Anghinah R, Braga NIO, et al. Recomendações para o registro/interpretação do mapeamento topográfico do eletrencefalograma e potenciais evocados: Parte II. correlações clínicas. Arq Neuropsiquiatr 1999;57:132-146.
51. Fonseca LC. Projeta Diretrizes. Demência-Eletroencefalograma e EEG quantitativo. AMB/CFM 2002.
52. Clauss JJ, Strijers RL, Jonkman EJ. The diagnostic value of EEG in mild senile AD. Clin Neurophysiol 1999;110:825-832.
53. Robinson DJ, Merskey H, Blume WT. Electroencephalography as an aid in the exclusion of AD. Arch Neurol 1994;51:280-284.
54. Strijers RL, Scheltens P, Jenkman EJ. Diagnosting AD in community - dwelling elderly: a comparison of EEG and MRI. Dement Geriatr Cogn Disord 1997;8:198-202.
55. Poser S, Mollenhauer B, Kraubera A. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999;122:2345-2351.
56. Duffy FH, Albert MS, McAnulty G, Garvey AJ. Age-related differences in brain electrical activity of healthy subjects. Ann Neurol 1984;16:430-438.
57. Valdés P, Valdés M, Carballo JA, et al. qEEG in a public health system. Brain Topogr 1992;4:259-266.
58. Duffy FH, Albert MS, McAnulty G. Brain electrical activity in patients with presenile and senile dementia of Alzheimer type. Ann Neurol 1984;16:439-448.
59. Holschneider DP, Leuchter AF. Beta activity in aging and dementia. Brain Topogr 1995;8:169-180.
60. Nuwer MR. On the process for evaluating proposed new diagnostic EEG tests. Brain Topogr 1992;4:243-247.
61. Duffy FH, Burchfiel JL, Lombroso CTD. Brain electrical activity mapping (BEAM): a method for extending the clinical utility of EEG and evoked potential data. Ann Neurol 1979;5:309-321.
62. Goodin DS, Squires KC, Starr A. Long latency event-related components of the auditory evoked potential in dementia. Brain 1978;101:635-648.
63. Maurer K, Dierks T, Strik WK, Frölich L. P3 in psychiatry and psychopharmacology. Brain Topogr 1990;3:79-84.
64. Maurer K, Dierks T. Atlas of brain mapping: topographic mapping of EEG and evoked potentials. Berlin: springer-Verlag, 1991.
65. Polich J, Ladish C, Bloom FE. P300 assessment of early Alzheimer's disease. Electroenceph Clin Neurophysiol 1990;77:179-189.
66. Verma NP, Nichols CD, Greiffenstein MF, Singh RP, Hurst-Gordon D. Waves earlier than P3 are more informative in putative subcortical dementias: a study with mapping and neuropsychological techniques. Brain Topogr 1989;1:183-192.
67. Hamburger HL, Triantafyllou NI. Clinical applications of auditory event related potentials in neurology. Brain Topogr 1990;3:49-52.
68. Roemer RA, Shagass C, Dubin W, Jaffe R, Siegal L. Quantitative EEG in elderly depressives. Brain Topogr 1992;4:285-290.
69. DeToledo-Morrell L, Morrel F. Alzheimer's disease: new developments for noninvasive detection of early cases. Curr Opin Neurol Neurosurg 1993;6:113-118.